Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Flow cytometry for pediatric platelets.
Ignatova AA, Ponomarenko EA, Polokhov DM, Suntsova EV, Zharkov PA, Fedorova DV, Balashova EN, Rudneva AE, Ptushkin VV, Nikitin EA, Shcherbina A, Maschan AA, Novichkova GA, Panteleev MA. Ignatova AA, et al. Among authors: ptushkin vv. Platelets. 2019;30(4):428-437. doi: 10.1080/09537104.2018.1513473. Epub 2018 Oct 4. Platelets. 2019. PMID: 30285517
Evolution of platelet function in adult patients with chronic immune thrombocytopenia on romiplostim treatment.
Ignatova AA, Demina IA, Ptushkin VV, Khaspekova SG, Shustova ON, Pankrashkina MM, Ryabykh AA, Obydennyi SI, Strelkova OS, Polokhov DM, Seregina EA, Poletaev AV, Ataullakhanov FI, Kireev II, Mazurov AV, Maschan AA, Novichkova GA, Panteleev MA. Ignatova AA, et al. Among authors: ptushkin vv. Br J Haematol. 2019 Oct;187(2):e38-e42. doi: 10.1111/bjh.16164. Epub 2019 Aug 18. Br J Haematol. 2019. PMID: 31422582 Free article. No abstract available.
[Multiple myeloma: response to treatment and survival of patients according to the interim analysis of the Russian observational, retrospective-prospective, multicenter cohort study (MULTISPECT)].
Ptushkin VV, Kunst MA, Mitina TA, Konstantinova TS, Rachkova NN, Shelekhova TV, Elykomov IV, Kuchma GB, Farizova KO, Vinogradova OY, Nikitin EA, Pashanov ED. Ptushkin VV, et al. Ter Arkh. 2022 Aug 12;94(7):827-835. doi: 10.26442/00403660.2022.07.201718. Ter Arkh. 2022. PMID: 36286939 Russian.
A phase-II study of atezolizumab in combination with obinutuzumab or rituximab for relapsed or refractory mantle cell or marginal zone lymphoma or Waldenström's macroglobulinemia.
Panayiotidis P, Tumyan G, Thieblemont C, Ptushkin VV, Marin-Niebla A, García-Sanz R, Le Gouill S, Stathis A, Bottos A, Hamidi H, Katz P, Perretti T, Willis JC, Buske C. Panayiotidis P, et al. Among authors: ptushkin vv. Leuk Lymphoma. 2022 May;63(5):1058-1069. doi: 10.1080/10428194.2021.2015765. Epub 2022 Jan 19. Leuk Lymphoma. 2022. PMID: 35045765 Clinical Trial.
[Epidemiology of multiple myeloma in city Moscow].
Vinogradova OY, Ptushkin VV, Chernikov MV, Kochkareva YB, Zherebtsova VA. Vinogradova OY, et al. Among authors: ptushkin vv. Ter Arkh. 2019 Jul 15;91(7):83-92. doi: 10.26442/00403660.2019.07.000305. Ter Arkh. 2019. PMID: 32598740 Russian.
[Results of phase Ib open multicenter clinical trial of the safety, pharmacokinetics and pharmacodynamics of first biosimilar of eculizumab in untreated patients with paroxysmal nocturnal hemoglobinuria during induction of therapy].
Ptushkin VV, Kulagin AD, Lukina EA, Davydkin IL, Konstantinova TS, Shamrai VS, Minaeva NV, Kudlay DA, Gapchenko EV, Markova OA, Borozinets AY. Ptushkin VV, et al. Ter Arkh. 2020 Sep 1;92(7):77-84. doi: 10.26442/00403660.2020.07.000818. Ter Arkh. 2020. PMID: 33346448 Clinical Trial. Russian.
COVID-19 in patients with chronic lymphocytic leukemia: a Moscow observational study.
Kochneva ОL, Kislova M, Zhelnova EI, Petrenko AA, Baryakh EA, Yatskov KV, Dmitrieva EA, Misurina EN, Nikitin KE, Vasilieva EJ, Samsonova IV, Ptushkin VV, Baranova A, Nikitin EA. Kochneva ОL, et al. Among authors: ptushkin vv. Leuk Lymphoma. 2022 Jul;63(7):1607-1616. doi: 10.1080/10428194.2022.2034157. Epub 2022 Feb 13. Leuk Lymphoma. 2022. PMID: 35156528
36 results